These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


74 related items for PubMed ID: 20074801

  • 21. Oligonucleotide IMT504 induces an immunogenic phenotype and apoptosis in chronic lymphocytic leukemia cells.
    Rodriguez JM, Elias F, Montaner A, Flo J, Lopez RA, Zorzopulos J, Franco RJ, Lenial SP, Lopez Salón M, Pirpignani ML, Solimano J, Garay G, Riveros D, Fernandez J, Cacchione R, Dupont J.
    Medicina (B Aires); 2006; 66(1):9-16. PubMed ID: 16555722
    [Abstract] [Full Text] [Related]

  • 22. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D, Wojtowicz M, Ciszak L, Kosmaczewska A, Frydecka I, Potoczek S, Urbaniak-Kujda D, Kapelko-Slowik K, Kuliczkowski K.
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [Abstract] [Full Text] [Related]

  • 23. The effects of CpG ODN on CLL proliferation, apoptosis or phenotype could have an impact on its clinical utility.
    Jahrsdorfer B, Blackwell S, Weiner G.
    Leukemia; 2007 Nov; 21(11):2354-5; author reply 2355-6. PubMed ID: 17657215
    [No Abstract] [Full Text] [Related]

  • 24. Phosphorothioate oligodeoxyribonucleotides induce in vitro proliferation of chicken B-cells.
    Wattrang E.
    Vet Immunol Immunopathol; 2009 Oct 15; 131(3-4):218-28. PubMed ID: 19447503
    [Abstract] [Full Text] [Related]

  • 25. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A, Garcia-Suarez J, Reyes E, Lapeña P, Hernandez M, Alvarez-Mon M.
    Exp Hematol; 1993 Nov 15; 21(12):1563-9. PubMed ID: 8405237
    [Abstract] [Full Text] [Related]

  • 26. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
    Molica S.
    Haematologica; 1997 Nov 15; 82(6):705-9. PubMed ID: 9499672
    [Abstract] [Full Text] [Related]

  • 27. Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.
    Put N, Konings P, Rack K, Jamar M, Van Roy N, Libouton JM, Vannuffel P, Sartenaer D, Ameye G, Speleman F, Herens C, Poirel HA, Moreau Y, Hagemeijer A, Vandenberghe P, Michaux L, Belgian Cytogenetic Group for Hemato-Oncology (BCGHO).
    Genes Chromosomes Cancer; 2009 Oct 15; 48(10):843-53. PubMed ID: 19582829
    [Abstract] [Full Text] [Related]

  • 28. Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study.
    Heerema NA, Byrd JC, Dal Cin PS, Dell' Aquila ML, Koduru PR, Aviram A, Smoley SA, Rassenti LZ, Greaves AW, Brown JR, Rai KR, Kipps TJ, Kay NE, Van Dyke DL, Chronic Lymphocytic Leukemia Research Consortium.
    Cancer Genet Cytogenet; 2010 Dec 15; 203(2):134-40. PubMed ID: 21156225
    [Abstract] [Full Text] [Related]

  • 29. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
    Mankaï A, Buhé V, Hammadi M, Youinou P, Ghedira I, Berthou C, Bordron A.
    Ann N Y Acad Sci; 2009 Sep 15; 1173():721-8. PubMed ID: 19758221
    [Abstract] [Full Text] [Related]

  • 30. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
    Caballero D, García-Marco JA, Martino R, Mateos V, Ribera JM, Sarrá J, León A, Sanz G, de la Serna J, Cabrera R, González M, Sierra J, San Miguel J.
    Clin Cancer Res; 2005 Nov 01; 11(21):7757-63. PubMed ID: 16278397
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
    Giannopoulos K, Schmitt M, Kowal M, Własiuk P, Bojarska-Junak A, Roliński J, Dmoszyńska A.
    Leuk Res; 2008 Dec 01; 32(12):1815-9. PubMed ID: 18499249
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [CpG-oligodeoxynucleotide stimulation improves the success for karyotypic analysis of chronic lymphocytic leukemia cells].
    Liu Q, Xu W, Qiu HR, Wang R, Yu H, Fan L, Miao KR, Li JY.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Sep 01; 30(9):601-4. PubMed ID: 19954619
    [Abstract] [Full Text] [Related]

  • 37. Mechanistic Insights into CpG DNA and IL-15 Synergy in Promoting B Cell Chronic Lymphocytic Leukemia Clonal Expansion.
    Gupta R, Yan XJ, Barrientos J, Kolitz JE, Allen SL, Rai K, Chiorazzi N, Mongini PKA.
    J Immunol; 2018 Sep 01; 201(5):1570-1585. PubMed ID: 30068596
    [Abstract] [Full Text] [Related]

  • 38. [Application of CpG Oligodeoxynucleotide Immunostimulation in Chromosome Study of Chronic Lymphoblastic Leukemia].
    Mai DI Na AEK, Liu H, Wang YL, Wang YC, Huang Q, Wang ZS, Gu ZLNE, Lang T, Nie YL, An L, A ZGL, Mu HTBE, Zhang XY, Fu L, Ai HMJ, Mao M, Wang XM, Li Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr 01; 28(2):470-475. PubMed ID: 32319381
    [Abstract] [Full Text] [Related]

  • 39. CpG stimulation of chronic lymphocytic leukemia cells induces a polarized cell shape and promotes migration in vitro and in vivo.
    Dampmann M, Görgens A, Möllmann M, Murke F, Dührsen U, Giebel B, Dürig J.
    PLoS One; 2020 Apr 01; 15(2):e0228674. PubMed ID: 32040489
    [Abstract] [Full Text] [Related]

  • 40. Culture and Harvest of CpG-Stimulated Peripheral Blood or Bone Marrow in Chronic Lymphocytic Leukemia.
    Miller CR, Heerema NA.
    Methods Mol Biol; 2019 Apr 01; 1881():27-34. PubMed ID: 30350195
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.